Health Matthew Herper and Helen Branswell FDA advisory panel votes unanimously that Pfizer and Moderna shots be authorized for young children
Health Helen Branswell and Matthew Herper Tracking an FDA advisory panel meeting on Covid vaccines in young children
First Opinion Steve Brozak and Richard Marfuggi Lessons from earlier pandemics: Vaccine panel must discuss imprinting among infants and toddlers
Pharmalot Ed Silverman Pharmalittle: Canada OKs ALS drug still waiting FDA approval; WTO talks on Covid patent waiver are down to the wire
First Opinion Thomas B. Cueni Waiving intellectual property rights is a flawed solution to achieving Covid-19 vaccine equity
Pharmalot Ed Silverman Pharmalittle: FDA panel endorses Bluebird Bio gene therapy for rare disease; GSK touts RSV vaccine trial results
The Readout LOUD Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy
Health Kate Sheridan Homeless and incarcerated people in Minnesota struggled to access Covid vaccines
First Opinion Muhammad Yunus Preparing for the next pandemic: Time to follow a social business model for patent-free global medicine production
The Readout LOUD Adam Feuerstein and Meg Tirrell An emergency doctor and parent sorts through Covid vaccine options for kids under 5
The Readout LOUD Adam Feuerstein and Meg Tirrell Listen: Covid vaccines for the youngest kids, ASCO preview, & a biotech CEO’s arrest on murder charges
Pharmalot Ed Silverman Pharmalittle: Cancer coalition aims to boost access to meds in poor countries; Moderna’s vaccine patent defense poses shield for others
Health Matthew Herper CDC recommends Covid boosters for kids ages 5 to 11 after advisory committee vote
Health Elizabeth Cooney Large U.K. study links vaccination after Covid infection to lower odds of long Covid symptoms
Health Lauran Neergaard — Associated Press FDA clears Covid booster shot for healthy kids ages 5 to 11
Pharmalot Ed Silverman National Institutes of Health licenses nearly a dozen Covid-19 technologies to a WHO program
Politics Lev Facher Dr. Oz peddles medical misinformation — but could his political rise have a silver lining for public health?
Pharmalot Ed Silverman Why a controversial patent rights waiver could be a ‘missed opportunity’ to tackle the next pandemic
Pharmalot Ed Silverman A compromise on patent waivers for Covid-19 vaccines takes a key step at the WTO
First Opinion Els Torreele Global health should not be determined by pharma investors and shareholders
Pharmalot Ed Silverman U.N. committee urges wealthy nations to honor human rights and widen access to Covid vaccines